Form 4: Flora Growth Director's Stock Appreciation Rights Repriced to Lower Exercise Price

Flora Growth Corp. director Manfred Leventhal's Stock Appreciation Rights (SARs) were amended with shareholder approval, lowering their exercise price from $1.30 to $0.58.

Summary

• Manfred Leventhal, a Director of Flora Growth Corp. (FLGC), reported a change in his beneficial ownership of Stock Appreciation Rights (SARs).
• On June 30, 2025, 5,000 SARs with an exercise price of $1.30 were effectively disposed of.
• Simultaneously, 5,000 SARs with a new, lower exercise price of $0.58 were acquired.
• This amendment, which repriced the SARs, was granted on December 15, 2024, and received shareholder approval.
• The SARs have an expiration date of December 15, 2034.

Sentiment

Score: 3

Explanation: The repricing of Stock Appreciation Rights to a lower exercise price, while potentially re-incentivizing management, generally signals past underperformance of the company's stock, which is a negative indicator for investors.

Positives

• The repricing of Stock Appreciation Rights (SARs) to a lower exercise price of $0.58 from $1.30 could re-incentivize the director, Manfred Leventhal, by making the SARs more likely to be 'in the money' and thus more valuable.
• Shareholder approval for the amendment indicates alignment between the company's board and its shareholders regarding executive compensation adjustments.

Negatives

• The repricing of Stock Appreciation Rights (SARs) typically occurs when the company's stock price has fallen below the original exercise price, suggesting past underperformance of the stock.
• A lower exercise price means that the director can benefit from a smaller increase in the company's stock price, potentially diluting the value for existing shareholders if the SARs are exercised.

Future Outlook

The document does not provide forward-looking statements or guidance beyond the expiration date of the SARs.

Industry Context

This Form 4 filing is a standard disclosure of an insider transaction related to executive compensation. Repricing of Stock Appreciation Rights (SARs) or stock options is a common practice in industries where stock prices have significantly declined, aiming to restore the incentive value of equity awards for management.

Corporate Governance

Stakeholder Impact

• Shareholders: The repricing of SARs could be viewed negatively as it often indicates past stock underperformance and may lead to increased potential dilution if the stock price rises above the new, lower exercise price.
• Director (Manfred Leventhal): The repriced SARs provide renewed incentive and potential future compensation, as they are now more likely to be 'in the money' given the lower exercise price.

Next Steps

• The Stock Appreciation Rights will remain exercisable until their expiration date of December 15, 2034.

Key Dates

Keywords

Flora Growth Corp, FLGC, SEC Form 4, Stock Appreciation Rights, SARs, executive compensation, director, insider transaction, Manfred Leventhal, shareholder approval